X
Email:
sales@ruixibiotech.com

PHT‐PPY‐PDA‐ANG NPs

PHT‐PPY‐PDA‐brain‐targeting peptide ANG nanoparticles

Catalog # Pkg Size Price(USD) Quantity Buy this product
R-M2-9991 50mg inquiry

Product description

The surface of PHT‐PPY‐PDA was further chemically conjugated with thiol‐PEGylated brain‐targeting peptide ANG,which enhances BBB penetration through interacting with the LDLR1. Moreover, PHT‐PPY‐PDA exhibited a 125‐fold escalation in conductivity compared to pure PPY, enabling rapid release of PHT upon the onset of epileptic discharges.
In an acute seizure model induced by pentylenetetrazole, treatment with PHT‐PPY‐PDA‐ANG/Phenytoin-Polypyrrole-polydopamine‐brain‐targeting peptide ANG nanoparticles(10 mg PHT kg−1) and NIR irradiation significantly reduced seizure severity, increased latency to GS and improved survival rates. In a pilocarpine‐induced epilepsy model mimicking clinical SE, sustained release of PHT‐PPY‐PDA‐ANG‐10 + NIR remarkably mitigated SE severity with a low incidence of GS and no SE behavior.

PHT‐PPY‐PDA‐ANG NPs

Appearance Freeze-dried powder
Solubility N/A
Synonyms Phenytoin-Polypyrrole-polydopamine‐brain‐targeting peptide ANG nanoparticles
Storage -20℃, protected from light and moisture
Transportation 4-25℃ temperature for up to 2 weeks
Stability 1 year
Document

Related Product